News Search Results
Aug 26, 2025, 08:30 ET ADCs in Oncology Trials: Practical Strategies for Clinical Development Success, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 26, 2025, 08:05 ET Rigel to Participate in Upcoming September Investor Conferences
Aug. 26, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president
More news about: Rigel Pharmaceuticals, Inc.
Aug 26, 2025, 08:05 ET INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults
MEETING, Pa., Aug. 26, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious
More news about: INOVIO Pharmaceuticals, Inc.
Aug 26, 2025, 08:00 ET Corteva Appoints Jennifer Johnson Chief Legal Officer
represented pharmaceutical and biotechnology companies in patent litigation. Johnson serves on the Advisory Board of the New York Botanical Garden. She previously served on the Board of Directors of the California Life Sciences Association and has taught biotechnology law at the University
More news about: Corteva, Inc.
Aug 26, 2025, 08:00 ET Theradaptive Treats First Patient in RESTORE Feasibility Study Evaluating OsteoAdapt™ DE in Dental Procedures
Theradaptive, Inc., a clinical-stage biotechnology company pioneering targeted protein therapeutics for tissue regeneration, today announced that the first patient has been successfully treated in
More news about: Theradaptive
Aug 26, 2025, 07:30 ET Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September
Aug. 26, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on immune response detection and diagnostics, today announced it has signed a Research Services Agreement ("RSA") with Emory
More news about: Virax BioLabs Group Limited
Aug 26, 2025, 07:00 ET Nanoscope Announces Groundbreaking 3-Year REMAIN Trial Data for Patients with Retinitis Pigmentosa at 2025 Euretina Congress and Retina Society Annual Scientific Meeting
Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel disease-agnostic therapies for patients with photoreceptor loss and vision impairment
More news about: Nanoscope Therapeutics
Aug 26, 2025, 06:45 ET Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Aug 26, 2025, 04:00 ET High-Precision Base Editing Clinical Treatment for Sickle Cell Disease -- CorrectSequence Therapeutics' CS-101 Achieves Promising Results in First Patient
Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base Editing (tBE) technology for the treatment of severe diseases, today announced the successful treatment of the
More news about: CorrectSequence Therapeutics
Aug 26, 2025, 02:00 ET High-Precision Base Editing Clinical Treatment for Sickle Cell Disease -- CorrectSequence Therapeutics' CS-101 Achieves Promising Results in First Patient
Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base Editing (tBE) technology for the treatment of severe diseases, today announced the successful treatment of the
More news about: CorrectSequence Therapeutics
Aug 26, 2025, 01:36 ET CAPR Stockholders with Large Losses Should Contact Robbins LLP Before the Lead Plaintiff Deadline for Information About Leading the Capricor Therapeutics, Inc. Class Action Lawsuit
securities between October 9, 2024 and July 10, 2025. Capricor is a clinical-stage biotechnology company that engages in the development of transformative cell and exosome-based therapeutics for treating
More news about: Robbins LLP
Aug 25, 2025, 15:54 ET Essa Pharma Inc. Clarifies Nasdaq Due Bill Trading for Previously Announced Cash Distribution
the business of the Company pursuant to the Company's previously announced transaction with XenoTherapeutics, Inc. ("Xeno"), a non-profit biotechnology company, under which Xeno will acquire all of the issued and outstanding Common Shares (the "Transaction"), the Nasdaq Stock Market LLC ("Nasdaq")
More news about: ESSA Pharma Inc.
Aug 25, 2025, 13:04 ET Human Longevity Taps Alamar Biosciences to Power Proteomic Innovation in Longevity Research
AI, multi-omics, and next-generation diagnostics. About Human Longevity, Inc. Founded in 2013, Human Longevity, Inc. is a biotechnology company at the forefront of integrating genomics, AI, and multimodal diagnostics to extend human healthspan. Through its flagship Executive Health
More news about: Human Longevity, Inc.
Aug 25, 2025, 13:03 ET Future Origins Receives National Award for Green Chemistry from ACS
Award in London on November 13, 2025. Future Origins was founded by industrial biotechnology leader Geno, in partnership with Unilever, Kao, and L'Oréal. Geno has been awarded the Presidential Green Chemistry Challenge Award four times previously
More news about: Future Origins
Aug 25, 2025, 11:38 ET Thryv Therapeutics to Present at the 2025 European Society of Cardiology Congress in Madrid, Spain
MONTREAL, Aug. 25, 2025 /PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company, today announced that Dr. Saumya Das will present compelling new preclinical results on its lead compound,
More news about: Thryv Therapeutics Inc.
Aug 25, 2025, 11:16 ET Prebiotic Fiber Market to Reach USD 2.3 Billion by 2031, Fueled by Gut Health & Functional Foods Boom | Valuates Reports
BeneoTereosSensusCosucraThe Tierra GroupTinjoy HealthcareChengdu iMOS BiotechnologyBiomartLallemandOrffaFUBON / Angel YeastSensientBiofeedGuangdong VTR
More news about: Valuates Reports
Aug 25, 2025, 10:45 ET Patent Search Software Market is expected to generate a revenue of USD 2.28 Billion by 2031, Globally, at 12.32% CAGR: Verified Market Research®
Global Patent Database Market Size By Patent Type (Utility Patents, Design Patents), By Industry Application (Information Technology, Biotechnology), By Patent Stage (Pending Patents, Granted Patents), By Ownership Structure (Individual Inventors, Small and Medium Enterprises), By Geography,
More news about: Verified Market Research
Aug 25, 2025, 10:01 ET Single Cell Sequencing Market worth $3.46 billion by 2030 with 12.2% CAGR | MarketsandMarkets™
driven by its well-established healthcare infrastructure, substantial investments in life sciences research, and the strong presence of leading biotechnology and pharmaceutical companies. The region demonstrates a high adoption rate of single cell sequencing technologies such as scRNAseq and scDNAseq,
More news about: MarketsandMarkets
Aug 25, 2025, 10:00 ET Clongen Laboratories, LLC Announces Launch of Sister Company Clongen Pharma, LLC in March 2026
-- Clongen Laboratories, LLC, a provider of molecular diagnostic services for infectious diseases and a contract research organization for the biotechnology industry, announces plans to launch a sister company, Clongen Pharma, LLC in March 2026. This expansion aims to offer
More news about: Clongen Laboratories, LLC
Aug 25, 2025, 09:13 ET Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that management will participate in the H.C. Wainwright 27th
More news about: Anixa Biosciences, Inc.
Aug 25, 2025, 09:00 ET Lilly to participate in Morgan Stanley 23rd Annual Global Healthcare Conference
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Aug 25, 2025, 09:00 ET REPATHA® NOW INDICATED FOR ADULTS AT INCREASED RISK FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS DUE TO UNCONTROLLED LDL-C
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Aug 25, 2025, 08:30 ET AI in Regulatory Medical Writing: Balancing Innovation with Human Expertise, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 25, 2025, 08:30 ET ADC Development: Early On- and Off-Target Testing to Fail Fast, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 25, 2025, 08:05 ET INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
MEETING, Pa., Aug. 25, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious
More news about: INOVIO Pharmaceuticals, Inc.